Later, the company's stock zoomed 37.30 per cent to Rs 1,384 on BSE and 37.40 per cent to Rs 1,…

Pune-based Emcure Pharma, a pharmaceutical company that develops, manufactures and markets a wide r…

Retail investors can buy a minimum of 1 lot (14 shares) at ​Rs 14,112, or 14 lots (196 shares) at R…

The IPO comprises fresh issuance of equity shares worth Rs 800 crore and an Offer For Sale (OFS…

HDFC Bank (down by 4.5%), Titan (down by 1.90%), LTI Mindtree (down by 0.85%), Tata Steel (down by …

The Income Tax department on Thursday conducted searches on the premises of Mankind Pharma over all…

After a lull period of over four months in 2023, the stellar debut of Mankind Pharma has rekindled …

Gland Pharma Limited, a generic injectable focused contract development and manufacturing compa…

Ahmedabad-based pharma company Concord Biotech made its D-street debut at a 21% premium on Friday, …

Ahmedabad-based pharma company Concord Biotech received a tepid response from investors on the firs…

Condom manufacturer Mankind Pharma is likely to announce the allotment status of its initial public…

After listing at a 20% premium, condom manufacturer Mankind Pharma’s stock ran up 9.5% on Tuesday. …

The IPO will comprise an offer for sale (OFS) of over 4 crore equity shares by the promoters a…

The initial share sale of drug maker Mankind Pharma will open for public subscription on April 25.

Riding high on the positive momentum seen in 2021, many stocks gave stellar returns to investors…

Investors who stuck with Gland Pharma despite the ₹6,480 crore initial public offer (IPO) receiving…

After a huge market fall, Indian markets may open on a positive note as SGX Nifty, an early indicat…

After receiving a tepid response from investors, the ₹6,480 crore IPO of Gland Pharma closed on Wed…

The shares of the recently concluded Gland Pharma IPO are soaring in the grey market ahead of its l…

The shares of Gland pharma are seeing a stellar demand from investors post the IPO listing. The IPO…